B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Rebastinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rebastinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ponatinib
53 shared targets
foretinib
89 shared targets
ast
92 shared targets
doramapimod
56 shared targets
cediranib
52 shared targets
pazopanib
59 shared targets
vandetanib
56 shared targets
tozasertib
79 shared targets
quizartinib
45 shared targets
nintedanib
82 shared targets
Loading evidence profile...

This evidence profile for Rebastinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.